¥1,389.00 ($8.79)

+20.00 (+1.46%)

Weekly Expected Move ±3.1%

¥1285 ¥1327 ¥1369 ¥1411 ¥1453

JPX · Healthcare · Medical - Care Facilities · Tech Score Neutral · Power 47 · ¥44.7B mcap · 17M float · 0.591% daily turnover

Revenue

$46.7B -2.4% ▼

5Y CAGR: +18.9%

Gross Profit

$7.2B -12.8% ▼

5Y CAGR: +15.1%

Operating Income

$3.8B -28.6% ▼

5Y CAGR: +15.1%

Net Income

$2.9B -31.3% ▼

5Y CAGR: +19.5%

EPS (Diluted)

$89.77 -31.4% ▼

5Y CAGR: +17.9%

EBITDA

$5.7B -9.8% ▼

5Y CAGR: +19.5%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$23.0B	$29.1B	$37.9B	$47.8B	$46.7B
YoY Growth	+17.1%	+26.5%	+30.3%	+26.2%	-2.4%
Cost of Revenue	$19.0B	$24.4B	$31.0B	$39.5B	$39.4B
Gross Profit	$3.9B	$4.6B	$6.8B	$8.3B	$7.2B
Gross Margin	17.2%	16.0%	18.0%	17.4%	15.5%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$1.5B	$1.8B	$2.0B	$2.2B	$3.4B
Operating Expenses	$1.9B	$2.3B	$2.6B	$2.9B	$3.4B
Operating Income	$2.0B	$2.3B	$4.2B	$5.4B	$3.8B
Operating Margin	8.8%	7.9%	11.1%	11.3%	8.2%
Interest Expense	$47M	$67M	$58M	$55M	$102M
Income Before Tax	$2.3B	$4.5B	$4.9B	$6.4B	$4.4B
Tax Expense	$758M	$1.6B	$1.7B	$2.1B	$1.5B
Net Income	$1.5B	$3.0B	$3.2B	$4.3B	$2.9B
Net Margin	6.7%	10.2%	8.5%	8.9%	6.3%
EPS (Diluted)	$47.01	$90.33	$98.08	$130.78	$89.77
EBITDA	$2.8B	$5.4B	$5.8B	$6.3B	$5.7B
Shares Outstanding	33M	33M	33M	33M	33M

Line Item	FY2023 Q2	FY2023 Q3	FY2023 Q4	FY2024 Q1	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1
Revenue	$8.6B	$11.0B	$18.2B	$9.9B	$10.2B	$10.3B	$16.4B	$11.0B
Cost of Revenue	$7.0B	$9.4B	$14.6B	$8.1B	$8.5B	$8.7B	$14.2B	$9.0B
Gross Profit	$1.6B	$1.6B	$3.6B	$1.8B	$1.7B	$1.6B	$2.2B	$2.0B
Gross Margin	18.6%	15.0%	20.0%	17.9%	17.0%	15.1%	13.4%	18.2%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$714M	$737M	$741M	$895M	$847M	$801M	$856M	$897M
Operating Expenses	$714M	$737M	$741M	$895M	$846M	$801M	$856M	$897M
Operating Income	$877M	$908M	$2.9B	$874M	$881M	$750M	$1.3B	$1.1B
Operating Margin	10.2%	8.3%	15.9%	8.9%	8.7%	7.3%	8.2%	10.0%
Interest Expense	$12M	$13M	$19M	$16M	$22M	$31M	$33M	$29M
Income Before Tax	$1.0B	$1.1B	$3.5B	$932M	$945M	$787M	$1.7B	$1.1B
Tax Expense	$363M	$385M	$1.1B	$301M	$304M	$216M	$634M	$354M
Net Income	$676M	$723M	$2.4B	$631M	$640M	$571M	$1.1B	$752M
Net Margin	7.9%	6.6%	13.2%	6.4%	6.3%	5.6%	6.7%	6.8%
EPS (Diluted)	$20.67	$22.11	$73.92	$19.30	$19.56	$17.46	$33.45	$22.99
EBITDA	$1.3B	$1.1B	$3.8B	$1.2B	$1.2B	$1.1B	$1.7B	$1.5B
Shares Outstanding	33M	33M	33M	33M	33M	33M	33M	33M

6062.T JPX